{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T04:07:28Z","timestamp":1746677248245,"version":"3.40.5"},"posted":{"date-parts":[[2025,5,7]]},"group-title":"In Review","reference-count":58,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,4,20]]},"abstract":"<title>Abstract<\/title>\n        <p>Although prior studies have reported a link between autoimmunity and carcinogenesis, the roles of genetic factors and potential mediators involved in this process remain elusive. We constructed disease-specific and combined polygenic risk scores (PRSs) for 6 common autoimmune diseases (AIDs) (systemic lupus erythematosus [SLE], rheumatoid arthritis, multiple sclerosis, Crohn's disease, ulcerative colitis [UC], and type 1 diabetes mellitus [T1D]) in the UK Biobank cohort. Compared to those without AID, AID patients at baseline had increased risks of overall cancer, hematological, digestive, and urinary cancer. The combined AID-PRS was significantly associated with increased risks of hematological cancer (HR [95% CI] per SD increase: 1.06 [1.03\u20131.09]) and non-Hodgkin's lymphoma (HR [95% CI] per SD increase: 1.10 [1.05\u20131.14]). For individual AID-PRSs, we identified 21 significant associations between 5 PRSs and 11 types of cancer in the overall population, along with 15 additional associations in the sex-stratified analysis. For example, SLE-, UC-, and T1D-PRS showed complex cross-cancer effects on risks of up to 6 cancer types. These associations were generally independent of immunosuppressant drug use. Differential associations of SLE-PRS with prostate cancer risk were found by prostate cancer PRS status (<italic>P<\/italic> <sub>interaction<\/sub>&lt;0.05). Several peripheral biomarkers, including red or white blood cell counts, platelet counts, and CRP partly mediated the PRS associations (up to 16.96%). Our study provides important insights into the role of autoimmune diseases in carcinogenesis, which also highlights opportunities for target cancer screening and prevention in potentially vulnerable populations.<\/p>","DOI":"10.21203\/rs.3.rs-6491161\/v1","type":"posted-content","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T09:21:22Z","timestamp":1746609682000},"source":"Crossref","is-referenced-by-count":0,"title":["Disentangling the Complex Relationships Between Autoimmune Diseases and Cancer Through Polygenic Risk Scores: Evidence from a Large Prospective Study"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4129-9403","authenticated-orcid":false,"given":"Xiang","family":"Shu","sequence":"first","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0046-6663","authenticated-orcid":false,"given":"Jing","family":"Sun","sequence":"additional","affiliation":[{"name":"Zhejiang University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"meng","family":"zhang","sequence":"additional","affiliation":[{"name":"Zhejiang University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxuan","family":"Li","sequence":"additional","affiliation":[{"name":"Zhejiang University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Yang","sequence":"additional","affiliation":[{"name":"Zhejiang University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Sun","sequence":"additional","affiliation":[{"name":"Zhejiang Chinese Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5062-4765","authenticated-orcid":false,"given":"Xinjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5269-1294","authenticated-orcid":false,"given":"Xingyi","family":"Guo","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Buas","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2024-0015","authenticated-orcid":false,"given":"Gordon","family":"Watt","sequence":"additional","affiliation":[{"name":"The Netherlands Cancer Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6880-2577","authenticated-orcid":false,"given":"Xue","family":"Li","sequence":"additional","affiliation":[{"name":"School of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 74(3):229\u2013263","journal-title":"Cancer J Clin"},{"issue":"16","key":"ref2","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray F","year":"2021","unstructured":"Bray F, Laversanne M, Weiderpass E, Soerjomataram I (2021) The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127(16):3029\u20133030","journal-title":"Cancer"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He X","year":"2020","unstructured":"He X, Xu C (2020) Immune checkpoint signaling and cancer immunotherapy. Cell Res 30(8):660\u2013669","journal-title":"Cell Res"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala S","year":"2021","unstructured":"Jhunjhunwala S, Hammer C, Delamarre L (2021) Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer 21(5):298\u2013312","journal-title":"Nat Rev Cancer"},{"issue":"19\u201320","key":"ref5","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1101\/gad.314617.118","article-title":"Roles of the immune system in cancer: from tumor initiation to metastatic progression","volume":"32","author":"Gonzalez H","year":"2018","unstructured":"Gonzalez H, Hagerling C, Werb Z (2018) Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev 32(19\u201320):1267\u20131284","journal-title":"Genes Dev"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.cell.2016.01.049","article-title":"The Basis of Oncoimmunology","volume":"164","author":"Palucka AK","year":"2016","unstructured":"Palucka AK, Coussens LM (2016) The Basis of Oncoimmunology. Cell 164(6):1233\u20131247","journal-title":"Cell"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41568-022-00544-4","article-title":"Mechanisms driving the immunoregulatory function of cancer cells","volume":"23","author":"Weverwijk A","year":"2023","unstructured":"van Weverwijk A, de Visser KE (2023) Mechanisms driving the immunoregulatory function of cancer cells. Nat Rev Cancer 23(4):193\u2013215","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan D","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674","journal-title":"Cell"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.semcancer.2019.06.005","article-title":"Autoimmune diseases and hematological malignancies: Exploring the underlying mechanisms from epidemiological evidence","volume":"64","author":"Hemminki K","year":"2020","unstructured":"Hemminki K, Huang W, Sundquist J, Sundquist K, Ji J (2020) Autoimmune diseases and hematological malignancies: Exploring the underlying mechanisms from epidemiological evidence. Sem Cancer Biol 64:114\u2013121","journal-title":"Sem Cancer Biol"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamaoncol.2021.5680","article-title":"Immune-Mediated Diseases Associated With Cancer Risks","volume":"8","author":"He MM","year":"2022","unstructured":"He MM, Lo CH, Wang K et al (2022) Immune-Mediated Diseases Associated With Cancer Risks. JAMA Oncol 8(2):209\u2013219","journal-title":"JAMA Oncol"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ijc.24287","article-title":"Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies","volume":"125","author":"Anderson LA","year":"2009","unstructured":"Anderson LA, Gadalla S, Morton LM et al (2009) Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer 125(2):398\u2013405","journal-title":"Int J Cancer"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrrheum.2011.62","article-title":"Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma","volume":"7","author":"Dias C","year":"2011","unstructured":"Dias C, Isenberg DA (2011) Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma. Nat Rev Rheumatol 7(6):360\u2013368","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jnci\/djad187","article-title":"Autoimmune disease and the risk of anal cancer in the US population aged 66 years and over","volume":"116","author":"Song M","year":"2024","unstructured":"Song M, Engels EA, Clarke MA, Kreimer AR, Shiels MS (2024) Autoimmune disease and the risk of anal cancer in the US population aged 66 years and over. J Natl Cancer Inst 116(2):309\u2013315","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.autrev.2009.07.004","article-title":"Malignancies in systemic lupus erythematosus","volume":"9","author":"Kiss E","year":"2010","unstructured":"Kiss E, Kovacs L, Szodoray P (2010) Malignancies in systemic lupus erythematosus. Autoimmun Rev 9(4):195\u2013199","journal-title":"Autoimmun Rev"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/cncr.25524","article-title":"Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans","volume":"117","author":"Landgren AM","year":"2011","unstructured":"Landgren AM, Landgren O, Gridley G, Dores GM, Linet MS, Morton LM (2011) Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer 117(6):1163\u20131171","journal-title":"Cancer"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/jjco\/hyy047","article-title":"Type 1 diabetes mellitus and risk of cancer: a meta-analysis of observational studies","volume":"48","author":"Sona MF","year":"2018","unstructured":"Sona MF, Myung SK, Park K, Jargalsaikhan G (2018) Type 1 diabetes mellitus and risk of cancer: a meta-analysis of observational studies. Jpn J Clin Oncol 48(5):426\u2013433","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis","volume":"17","author":"Simon TA","year":"2015","unstructured":"Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S (2015) Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res therapy 17(1):212","journal-title":"Arthritis Res therapy"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.autrev.2017.07.022","article-title":"Cancer and autoimmune diseases","volume":"16","author":"Giat E","year":"2017","unstructured":"Giat E, Ehrenfeld M, Shoenfeld Y (2017) Cancer and autoimmune diseases. Autoimmun Rev 16(10):1049\u20131057","journal-title":"Autoimmun Rev"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaut.2012.07.011","article-title":"Heritability versus the role of the environment in autoimmunity","volume":"39","author":"Selmi C","year":"2012","unstructured":"Selmi C, Lu Q, Humble MC (2012) Heritability versus the role of the environment in autoimmunity. J Autoimmun 39(4):249\u2013252","journal-title":"J Autoimmun"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ng.3760","article-title":"Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease","volume":"49","author":"Lange KM","year":"2017","unstructured":"de Lange KM, Moutsianas L, Lee JC et al (2017) Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet 49(2):256\u2013261","journal-title":"Nat Genet"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41467-021-21049-y","article-title":"Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups","volume":"12","author":"Wang YF","year":"2021","unstructured":"Wang YF, Zhang Y, Lin Z et al (2021) Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups. Nat Commun 12(1):772","journal-title":"Nat Commun"},{"issue":"7863","key":"ref22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41586-021-03552-w","article-title":"Interpreting type 1 diabetes risk with genetics and single-cell epigenomics","volume":"594","author":"Chiou J","year":"2021","unstructured":"Chiou J, Geusz RJ, Okino ML et al (2021) Interpreting type 1 diabetes risk with genetics and single-cell epigenomics. Nature 594(7863):398\u2013402","journal-title":"Nature"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41588-022-01213-w","article-title":"Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis","volume":"54","author":"Ishigaki K","year":"2022","unstructured":"Ishigaki K, Sakaue S, Terao C et al (2022) Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis. Nat Genet 54(11):1640\u20131651","journal-title":"Nat Genet"},{"issue":"6460","key":"ref24","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","author":"International Multiple Sclerosis Genetics C","year":"2019","unstructured":"International Multiple Sclerosis Genetics C (2019) Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science ;365(6460)","journal-title":"Science"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrg.2016.27","article-title":"Developing and evaluating polygenic risk prediction models for stratified disease prevention","volume":"17","author":"Chatterjee N","year":"2016","unstructured":"Chatterjee N, Shi J, Garcia-Closas M (2016) Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nat Rev Genet 17(7):392\u2013406","journal-title":"Nat Rev Genet"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12916-022-02506-x","article-title":"C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis","volume":"20","author":"Zhu M","year":"2022","unstructured":"Zhu M, Ma Z, Zhang X et al (2022) C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis. BMC Med 20(1):301","journal-title":"BMC Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12885-016-2115-6","article-title":"Inflammatory biomarker score and cancer: A population-based prospective cohort study","volume":"16","author":"Morrison L","year":"2016","unstructured":"Morrison L, Laukkanen JA, Ronkainen K, Kurl S, Kauhanen J, Toriola AT (2016) Inflammatory biomarker score and cancer: A population-based prospective cohort study. BMC Cancer 16:80","journal-title":"BMC Cancer"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow C","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N et al (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779","journal-title":"PLoS Med"},{"issue":"7726","key":"ref29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft C","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D et al (2018) The UK Biobank resource with deep phenotyping and genomic data. Nature 562(7726):203\u2013209","journal-title":"Nature"},{"issue":"17","key":"ref30","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1158\/0008-5472.CAN-21-0836","article-title":"Genetic Risk for Overall Cancer and the Benefit of Adherence to a Healthy Lifestyle","volume":"81","author":"Zhu M","year":"2021","unstructured":"Zhu M, Wang T, Huang Y et al (2021) Genetic Risk for Overall Cancer and the Benefit of Adherence to a Healthy Lifestyle. Cancer Res 81(17):4618\u20134627","journal-title":"Cancer Res"},{"key":"ref31","unstructured":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England). (2020) ;396(10258):1204\u20131222"},{"issue":"7","key":"ref32","doi-asserted-by":"crossref","first-page":"e036584","DOI":"10.1136\/bmjopen-2019-036584","article-title":"Incidence and prevalence of inflammatory bowel disease in UK primary care: a population-based cohort study","volume":"10","author":"Pasvol TJ","year":"2020","unstructured":"Pasvol TJ, Horsfall L, Bloom S et al (2020) Incidence and prevalence of inflammatory bowel disease in UK primary care: a population-based cohort study. BMJ open 10(7):e036584","journal-title":"BMJ open"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian J","year":"2023","unstructured":"Tian J, Zhang D, Yao X, Huang Y, Lu Q (2023) Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis 82(3):351\u2013356","journal-title":"Ann Rheum Dis"},{"issue":"17","key":"ref34","first-page":"2190","article-title":"METAL: fast and efficient meta-analysis of genomewide association scans","volume":"26","author":"Willer CJ","year":"2010","unstructured":"Willer CJ, Li Y, Abecasis GR (2010) METAL: fast and efficient meta-analysis of genomewide association scans. Bioinf (Oxford England) 26(17):2190\u20132191","journal-title":"Bioinf (Oxford England)"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1037\/a0020761","article-title":"A general approach to causal mediation analysis","volume":"15","author":"Imai K","year":"2010","unstructured":"Imai K, Keele L, Tingley D (2010) A general approach to causal mediation analysis. Psychol Methods 15(4):309\u2013334","journal-title":"Psychol Methods"},{"issue":"20","key":"ref36","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"Zintzaras E","year":"2005","unstructured":"Zintzaras E, Voulgarelis M, Moutsopoulos HM (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165(20):2337\u20132344","journal-title":"Arch Intern Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.leukres.2018.11.004","article-title":"Systemic lupus erythematosus and lymphoma: Incidence, pathogenesis and biology","volume":"75","author":"Klein A","year":"2018","unstructured":"Klein A, Polliack A, Gafter-Gvili A (2018) Systemic lupus erythematosus and lymphoma: Incidence, pathogenesis and biology. Leuk Res 75:45\u201349","journal-title":"Leuk Res"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/art.40396","article-title":"Abnormal B Cell Development in Systemic Lupus Erythematosus: What the Genetics Tell Us","volume":"70","author":"Karrar S","year":"2018","unstructured":"Karrar S, Cunninghame Graham DS (2018) Abnormal B Cell Development in Systemic Lupus Erythematosus: What the Genetics Tell Us. Arthritis Rheumatol 70(4):496\u2013507","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jnci\/djz219","article-title":"Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001\u20132015","volume":"112","author":"Deshmukh AA","year":"2020","unstructured":"Deshmukh AA, Suk R, Shiels MS et al (2020) Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001\u20132015. J Natl Cancer Inst 112(8):829\u2013838","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1200\/JCO.2017.74.9291","article-title":"Anal Cancer Risk Among People With HIV Infection in the United States","volume":"36","author":"Colon-Lopez V","year":"2018","unstructured":"Colon-Lopez V, Shiels MS, Machin M et al (2018) Anal Cancer Risk Among People With HIV Infection in the United States. J Clin Oncol 36(1):68\u201375","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ijc.33185","article-title":"A meta-analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale","volume":"148","author":"Clifford GM","year":"2021","unstructured":"Clifford GM, Georges D, Shiels MS et al (2021) A meta-analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale. Int J Cancer 148(1):38\u201347","journal-title":"Int J Cancer"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/NSS.S339230","article-title":"Daytime Sleep Behaviors and Cognitive Performance in Middle- to Older-Aged Adults Living with and without HIV Infection","volume":"14","author":"Li P","year":"2022","unstructured":"Li P, Gao L, Gao C et al (2022) Daytime Sleep Behaviors and Cognitive Performance in Middle- to Older-Aged Adults Living with and without HIV Infection. Nat Sci Sleep 14:181\u2013191","journal-title":"Nat Sci Sleep"},{"issue":"9","key":"ref43","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/jnci\/djac103","article-title":"Impact of HIV on Anal Squamous Cell Carcinoma Rates in the United States, 2001\u20132015","volume":"114","author":"Zhang ER","year":"2022","unstructured":"Zhang ER, Pfeiffer RM, Austin A et al (2022) Impact of HIV on Anal Squamous Cell Carcinoma Rates in the United States, 2001\u20132015. J Natl Cancer Inst 114(9):1246\u20131252","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/acr.22751","article-title":"Burden of Comorbidity in Systemic Lupus Erythematosus in the UK, 1999\u20132012","volume":"68","author":"Rees F","year":"2016","unstructured":"Rees F, Doherty M, Grainge M, Lanyon P, Davenport G, Zhang W (2016) Burden of Comorbidity in Systemic Lupus Erythematosus in the UK, 1999\u20132012. Arthritis Care Res (Hoboken) 68(6):819\u2013827","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.berh.2008.12.007","article-title":"Malignancy in systemic lupus erythematosus: what have we learned?","volume":"23","author":"Bernatsky S","year":"2009","unstructured":"Bernatsky S, Ramsey-Goldman R, Clarke AE (2009) Malignancy in systemic lupus erythematosus: what have we learned? Best Pract Res Clin Rheumatol 23(4):539\u2013547","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13075-018-1760-3","article-title":"The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis","volume":"20","author":"Song L","year":"2018","unstructured":"Song L, Wang Y, Zhang J, Song N, Xu X, Lu Y (2018) The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis. Arthritis Res therapy 20(1):270","journal-title":"Arthritis Res therapy"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.semarthrit.2021.09.009","article-title":"Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis","volume":"51","author":"Clarke AE","year":"2021","unstructured":"Clarke AE, Pooley N, Marjenberg Z et al (2021) Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis. Semin Arthritis Rheum 51(6):1230\u20131241","journal-title":"Semin Arthritis Rheum"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"105234","DOI":"10.1016\/j.ebiom.2024.105234","article-title":"Polygenic inheritance and its interplay with smoking history in predicting lung cancer diagnosis: a French-Canadian case-control cohort","volume":"106","author":"Boumtje V","year":"2024","unstructured":"Boumtje V, Manikpurage HD, Li Z et al (2024) Polygenic inheritance and its interplay with smoking history in predicting lung cancer diagnosis: a French-Canadian case-control cohort. EBioMedicine 106:105234","journal-title":"EBioMedicine"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cgh.2013.03.034","article-title":"Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation","volume":"12","author":"Kappelman MD","year":"2014","unstructured":"Kappelman MD, Farkas DK, Long MD et al (2014) Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol 12(2):265\u2013273e261","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/acr.24890","article-title":"Risk of Prostate Cancer in US Veterans With Rheumatoid Arthritis","volume":"75","author":"Wheeler AM","year":"2023","unstructured":"Wheeler AM, Roul P, Yang Y et al (2023) Risk of Prostate Cancer in US Veterans With Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 75(4):785\u2013792","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"ref51","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/art.11105","article-title":"Sex hormones and systemic lupus erythematosus: review and meta-analysis","volume":"48","author":"McMurray RW","year":"2003","unstructured":"McMurray RW, May W (2003) Sex hormones and systemic lupus erythematosus: review and meta-analysis. Arthritis Rheum 48(8):2100\u20132110","journal-title":"Arthritis Rheum"},{"issue":"5","key":"ref52","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eururo.2018.06.033","article-title":"Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer","volume":"74","author":"Liss MA","year":"2018","unstructured":"Liss MA, White JR, Goros M et al (2018) Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer. Eur Urol 74(5):575\u2013582","journal-title":"Eur Urol"},{"issue":"11","key":"ref53","first-page":"2059","article-title":"Tumor Necrosis Factor Inhibitors and the Risk of Cancer among Older Americans with Rheumatoid Arthritis. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research","volume":"30","author":"D'Arcy ME","year":"2021","unstructured":"D'Arcy ME, Beachler DC, Pfeiffer RM et al (2021) Tumor Necrosis Factor Inhibitors and the Risk of Cancer among Older Americans with Rheumatoid Arthritis. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research. cosponsored Am Soc Prev Oncol 30(11):2059\u20132067","journal-title":"cosponsored Am Soc Prev Oncol"},{"issue":"17","key":"ref54","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jama.2017.16071","article-title":"Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease","volume":"318","author":"Lemaitre M","year":"2017","unstructured":"Lemaitre M, Kirchgesner J, Rudnichi A et al (2017) Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease. JAMA 318(17):1679\u20131686","journal-title":"JAMA"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"23678","DOI":"10.1038\/s41598-024-75252-0","article-title":"Association between the neutrophil-to-lymphocyte ratio and cancer in adults from NHANES 2005\u20132018: a cross-sectional study","volume":"14","author":"Li GP","year":"2024","unstructured":"Li GP, Zhang D, Li MH et al (2024) Association between the neutrophil-to-lymphocyte ratio and cancer in adults from NHANES 2005\u20132018: a cross-sectional study. Sci Rep 14(1):23678","journal-title":"Sci Rep"},{"issue":"3","key":"ref56","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ijc.34986","article-title":"Associations between eosinophils and cancer risk in the UK Biobank","volume":"155","author":"Wang JH","year":"2024","unstructured":"Wang JH, Rabkin CS, Engels EA, Song M (2024) Associations between eosinophils and cancer risk in the UK Biobank. Int J Cancer 155(3):486\u2013492","journal-title":"Int J Cancer"},{"issue":"12","key":"ref57","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41577-021-00648-2","article-title":"Red blood cells join the ranks as immune sentinels","volume":"21","author":"Minton K","year":"2021","unstructured":"Minton K (2021) Red blood cells join the ranks as immune sentinels. Nat Rev Immunol 21(12):760\u2013761","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1038\/s41598-018-21387-w","article-title":"Red blood cells are dynamic reservoirs of cytokines","volume":"8","author":"Karsten E","year":"2018","unstructured":"Karsten E, Breen E, Herbert BR (2018) Red blood cells are dynamic reservoirs of cytokines. Sci Rep 8(1):3101","journal-title":"Sci Rep"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6491161\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6491161\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T09:21:34Z","timestamp":1746609694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6491161\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":58,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6491161\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,5,7]]},"subtype":"preprint"}}